PSME2
Basic information
Region (hg38): 14:24143362-24147570
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSME2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 0 | 2 |
Variants in PSME2
This is a list of pathogenic ClinVar variants found in the PSME2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24143423-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
14-24143489-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
14-24143586-T-C | not specified | Uncertain significance (May 09, 2023) | ||
14-24143593-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
14-24143599-G-C | not specified | Uncertain significance (Dec 13, 2022) | ||
14-24143652-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
14-24143661-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
14-24144015-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
14-24144230-G-C | Benign (Jun 11, 2018) | |||
14-24145409-G-A | Benign (Mar 02, 2018) | |||
14-24145422-G-T | not specified | Uncertain significance (Jun 21, 2023) | ||
14-24145425-G-T | not specified | Uncertain significance (Oct 22, 2021) | ||
14-24146219-G-T | not specified | Uncertain significance (Dec 13, 2022) | ||
14-24146233-A-G | not specified | Uncertain significance (Apr 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSME2 | protein_coding | protein_coding | ENST00000216802 | 11 | 4206 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0158 | 0.979 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.22 | 88 | 127 | 0.695 | 0.00000621 | 1566 |
Missense in Polyphen | 13 | 34.654 | 0.37514 | 517 | ||
Synonymous | 1.89 | 30 | 46.3 | 0.647 | 0.00000213 | 434 |
Loss of Function | 2.47 | 6 | 17.0 | 0.353 | 8.07e-7 | 204 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000293 | 0.000293 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome.;
- Pathway
- Antigen processing and presentation - Homo sapiens (human);Proteasome - Homo sapiens (human);Proteasome Degradation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Post-translational protein modification;Metabolism of proteins;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.657
- rvis_EVS
- 0.1
- rvis_percentile_EVS
- 61.28
Haploinsufficiency Scores
- pHI
- 0.830
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.961
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psme2
- Phenotype
- hematopoietic system phenotype; neoplasm; immune system phenotype;
Gene ontology
- Biological process
- positive regulation of endopeptidase activity;protein deubiquitination;interleukin-12-mediated signaling pathway;post-translational protein modification;regulation of proteasomal protein catabolic process;regulation of G1/S transition of mitotic cell cycle
- Cellular component
- proteasome complex;nucleoplasm;cytoplasm;cytosol;proteasome activator complex;membrane;extracellular exosome
- Molecular function
- protein binding;identical protein binding;endopeptidase activator activity